<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="gps5540" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Geriatr Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Int J Geriatr Psychiatry</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">GPS</journal-id><journal-title-group><journal-title>International Journal of Geriatric Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0885-6230</issn><issn pub-type="epub">1099-1166</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9292816</article-id><article-id pub-id-type="pmcid-ver">PMC9292816.1</article-id><article-id pub-id-type="pmcaid">9292816</article-id><article-id pub-id-type="pmcaiid">9292816</article-id><article-id pub-id-type="pmid">33778998</article-id><article-id pub-id-type="doi">10.1002/gps.5540</article-id><article-id pub-id-type="publisher-id">GPS5540</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Articles</subject></subj-group></article-categories><title-group><article-title>Neural correlates of the impulse dyscontrol domain of mild behavioral impairment</article-title></title-group><contrib-group><contrib id="gps5540-cr-0001" contrib-type="author"><name name-style="western"><surname>Gill</surname><given-names initials="S">Sascha</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9978-8691</contrib-id><xref rid="gps5540-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="gps5540-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="gps5540-cr-0002" contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="M">Meng</given-names></name><xref rid="gps5540-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="gps5540-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="gps5540-cr-0003" contrib-type="author"><name name-style="western"><surname>Mouches</surname><given-names initials="P">Pauline</given-names></name><xref rid="gps5540-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="gps5540-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="gps5540-cr-0004" contrib-type="author"><name name-style="western"><surname>Rajashekar</surname><given-names initials="D">Deepthi</given-names></name><xref rid="gps5540-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="gps5540-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="gps5540-cr-0005" contrib-type="author"><name name-style="western"><surname>Sajobi</surname><given-names initials="T">Tolulope</given-names></name><xref rid="gps5540-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="gps5540-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="gps5540-cr-0006" contrib-type="author"><name name-style="western"><surname>MacMaster</surname><given-names initials="FP">Frank P</given-names></name><xref rid="gps5540-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="gps5540-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><xref rid="gps5540-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="gps5540-cr-0007" contrib-type="author"><name name-style="western"><surname>Smith</surname><given-names initials="EE">Eric E</given-names></name><xref rid="gps5540-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="gps5540-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="gps5540-cr-0008" contrib-type="author"><name name-style="western"><surname>Forkert</surname><given-names initials="ND">Nils D</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2556-3224</contrib-id><xref rid="gps5540-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="gps5540-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="gps5540-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="gps5540-cr-0009" contrib-type="author" corresp="yes"><name name-style="western"><surname>Ismail</surname><given-names initials="Z">Zahinoor</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5529-3731</contrib-id><xref rid="gps5540-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="gps5540-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="gps5540-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="gps5540-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><xref rid="gps5540-aff-0007" ref-type="aff">
<sup>7</sup>
</xref><address><email>ismailz@ucalgary.ca</email></address></contrib><contrib id="gps5540-cr-0010" contrib-type="author"><collab collab-type="authors">for the Alzheimer's Disease Neuroimaging Initiative</collab></contrib></contrib-group><aff content-type="private-address" id="gps5540-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Hotchkiss Brain Institute</named-content>
<institution>Cumming School of Medicine, University of Calgary</institution>
<city>Calgary</city>
<named-content content-type="country-part">Alberta</named-content>
<country country="CA">Canada</country>
</aff><aff id="gps5540-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Neurosciences</named-content>
<institution>University of Calgary</institution>
<city>Calgary</city>
<named-content content-type="country-part">Alberta</named-content>
<country country="CA">Canada</country>
</aff><aff id="gps5540-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Community Health Science</named-content>
<institution>University of Calgary</institution>
<city>Calgary</city>
<named-content content-type="country-part">Alberta</named-content>
<country country="CA">Canada</country>
</aff><aff id="gps5540-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Radiology</named-content>
<institution>University of Calgary</institution>
<city>Calgary</city>
<named-content content-type="country-part">Alberta</named-content>
<country country="CA">Canada</country>
</aff><aff id="gps5540-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Psychiatry</named-content>
<institution>University of Calgary</institution>
<city>Calgary</city>
<named-content content-type="country-part">Alberta</named-content>
<country country="CA">Canada</country>
</aff><aff content-type="private-address" id="gps5540-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Addiction and Mental Health Strategic Clinical Network</named-content>
<institution>Alberta Health Services</institution>
<named-content content-type="country-part">Alberta</named-content>
<country country="CA">Canada</country>
</aff><aff content-type="private-address" id="gps5540-aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">O'Brien Institute for Public Health</named-content>
<institution>Cumming School of Medicine, University of Calgary</institution>
<city>Calgary</city>
<named-content content-type="country-part">Alberta</named-content>
<country country="CA">Canada</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Zahinoor Ismail, 3280 Hospital Drive NW, TRW Building 1st Floor, Calgary, AB T2N 4Z6, Canada.<break/>
Email: <email>ismailz@ucalgary.ca</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2021</year></pub-date><volume>36</volume><issue seq="120">9</issue><issue-id pub-id-type="pmc-issue-id">412625</issue-id><issue-id pub-id-type="doi">10.1002/gps.v36.9</issue-id><fpage>1398</fpage><lpage>1406</lpage><history><date date-type="received"><day>25</day><month>2</month><year>2021</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>18</day><month>07</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>20</day><month>07</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2022-07-29 10:19:40.070"><day>29</day><month>07</month><year>2022</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">© 2021 The Authors. International Journal of Geriatric =Psychiatry published by John Wiley &amp; Sons Ltd.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="GPS-36-1398.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:GPS-36-1398.pdf"/><abstract><title>Abstract</title><sec id="gps5540-sec-0001"><title>Objectives</title><p>Agitation and aggression are common in dementia and pre‐dementia. The dementia risk syndrome mild behavioral impairment (MBI) includes these symptoms in the impulse dyscontrol domain. However, the neural circuitry associated with impulse dyscontrol in neurodegenerative disease is not well understood. The objective of this work was to investigate if regional micro‐ and macro‐structural brain properties were associated with impulse dyscontrol symptoms in older adults with normal cognition, mild cognitive impairment, and Alzheimer's disease (AD).</p></sec><sec id="gps5540-sec-0002"><title>Methods</title><p>Clinical, neuropsychiatric, and T1‐weighted and diffusion‐tensor magnetic resonance imaging (DTI) data from 80 individuals with and 123 individuals without impulse dyscontrol were obtained from the AD Neuroimaging Initiative. Linear mixed effect models were used to assess if impulse dyscontrol was related to regional DTI and volumetric parameters.</p></sec><sec id="gps5540-sec-0003"><title>Results</title><p>Impulse dyscontrol was present in 17% of participants with NC, 43% with MCI, and 66% with AD. Impulse dyscontrol was associated with: (1) lower fractional anisotropy (FA), and greater mean, axial, and radial diffusivity in the fornix; (2) lesser FA and greater radial diffusivity in the superior fronto‐occipital fasciculus; (3) greater axial diffusivity in the cingulum; (4) greater axial and radial diffusivity in the uncinate fasciculus; (5) gray matter atrophy, specifically, lower cortical thickness in the parahippocampal gyrus.</p></sec><sec id="gps5540-sec-0004"><title>Conclusion</title><p>Our findings provide evidence that well‐established atrophy patterns of AD are prominent in the presence of impulse dyscontrol, even when disease status is controlled for, and possibly in advance of dementia. Our findings support the growing evidence for impulse dyscontrol symptoms as an early manifestation of AD.</p></sec></abstract><abstract abstract-type="short"><title>Key points</title><p>
<list list-type="bullet"><list-item><p>Impulse dyscontrol is a frequently endorsed domain of mild behavioral impairment (MBI), which is an at‐risk state for incident cognitive decline and dementia</p></list-item><list-item><p>Impulse dyscontrol is common in this sample of dementia and pre‐dementia participants at a frequency of 17% in normal cognition, 43% in mild cognitive impairment, and 66% in Alzheimer's disease</p></list-item><list-item><p>Impulse dyscontrol is associated with loss of white matter integrity in the cingulum, fornix, superior fronto‐occipital fasciculus, and uncinate fasciculus, as well as parahippocampal gyrus atrophy</p></list-item><list-item><p>This MBI domain may serve as a potential treatment target, even in advance of dementia</p></list-item></list>
</p></abstract><kwd-group><kwd id="gps5540-kwd-0001">aggression</kwd><kwd id="gps5540-kwd-0002">agitation</kwd><kwd id="gps5540-kwd-0003">Alzheimer's disease</kwd><kwd id="gps5540-kwd-0004">geriatric psychiatry</kwd><kwd id="gps5540-kwd-0005">impulse dyscontrol</kwd><kwd id="gps5540-kwd-0006">mild behavioral impairment</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Hotchkiss Brain Institute, University of Calgary
</institution><institution-id institution-id-type="doi">10.13039/100009003</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="3"/><page-count count="9"/><word-count count="5925"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC-ND</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2021</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.7 mode:remove_FC converted:18.07.2022</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="gps5540-cit-0057"><string-name name-style="western"><surname>Gill</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mouches</surname><given-names>P</given-names></string-name>, et al. <article-title>Neural correlates of the impulse dyscontrol domain of mild behavioral impairment</article-title><source>Int J Geriatr Psychiatry</source>. <year>2021</year>;<volume>36</volume>(<issue>9</issue>):<fpage>1398</fpage>–<lpage>1406</lpage>. <pub-id pub-id-type="doi">10.1002/gps.5540</pub-id><pub-id pub-id-type="pmid">33778998</pub-id><pub-id pub-id-type="pmcid">PMC9292816</pub-id></mixed-citation>
</p><fn-group><fn id="gps5540-note-0001"><p>Data used in preparation of this article was obtained from the Alzheimer's disease Neuroimaging Initiative (ADNI) database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://adni.loni.usc.edu" ext-link-type="uri">adni.loni.usc.edu</ext-link>). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://adni.loni.usc.edu/wpcontent/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf" ext-link-type="uri">http://adni.loni.usc.edu/wpcontent/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf</ext-link>.</p></fn></fn-group></notes></front><body id="gps5540-body-0001"><def-list list-content="abbreviations"><title>Abbreviations</title><def-item><term>AD</term><def><p>Alzheimer's disease</p></def></def-item><def-item><term>AxD</term><def><p>axial diffusivity</p></def></def-item><def-item><term>DTI</term><def><p>diffusion tensor imaging</p></def></def-item><def-item><term>FA</term><def><p>fractional anisotropy</p></def></def-item><def-item><term>ICV</term><def><p>intracranial volume</p></def></def-item><def-item><term>MBI</term><def><p>mild behavioral impairment</p></def></def-item><def-item><term>MBI‐C</term><def><p>Mild Behavioral Impairment Checklist</p></def></def-item><def-item><term>MD</term><def><p>mean diffusivity</p></def></def-item><def-item><term>MRI</term><def><p>magnetic resonance imaging</p></def></def-item><def-item><term>NC</term><def><p>Normal Cognition, NPI Neuropsychiatric Inventory</p></def></def-item><def-item><term>NPI‐Q</term><def><p>Neuropsychiatric Inventory Questionnaire</p></def></def-item><def-item><term>RD</term><def><p>radial diffusivity</p></def></def-item><def-item><term>SCD</term><def><p>subjective cognitive decline</p></def></def-item></def-list><sec id="gps5540-sec-0010"><label>1</label><title>INTRODUCTION</title><p>Mild behavioral impairment (MBI) is a validated neurobehavioral syndrome that describes the later life emergence of persistent neuropsychiatric symptoms (NPSs) as an at‐risk state for incident cognitive decline and dementia.<xref rid="gps5540-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> These NPS have been suggested to be an index manifestation of dementia.<xref rid="gps5540-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="gps5540-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="gps5540-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="gps5540-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="gps5540-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="gps5540-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="gps5540-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="gps5540-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="gps5540-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> MBI captures preclinical and prodromal disease symptoms and is associated with known dementia biomarkers including amyloid‐<italic toggle="yes">β</italic>,<xref rid="gps5540-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> tau,<xref rid="gps5540-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="gps5540-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> neurofilament light,<xref rid="gps5540-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> brain atrophy,<xref rid="gps5540-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="gps5540-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> and Alzheimer's disease (AD) risk genes.<xref rid="gps5540-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="gps5540-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Impulse dyscontrol is one of the MBI domains and includes behavioral symptoms of agitation/aggression, irritability, and aberrant motor behavior amongst others.</p><p>The clinical manifestations of MBI impulse dyscontrol including agitation, aggression, and irritability are common in dementia and are associated with caregiver stress and poorer outcomes.<xref rid="gps5540-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="gps5540-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> In a population‐based study of older adults ranging from normal cognition (NC) to mild cognitive impairment (MCI), cross‐sectional assessment of NPS using the neuropsychiatric inventory found impulse dyscontrol symptoms to be the most common domain with frequencies of 17.2% in NC and 33.8% in MCI.<xref rid="gps5540-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> A concurrent study in a cognitive neurology clinic sample assessed MBI domains in those with subjective cognitive decline (SCD) and MCI<xref rid="gps5540-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> and reported the frequency of impulse dyscontrol in both groups being greater than 50%.<xref rid="gps5540-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> Longitudinal analysis of the National Alzheimer Coordinating Center cohort described phases of NPS emergence in advance of dementia with symptoms of irritability/lability emerging in the first wave of pre‐dementia NPS, and agitation emerging in the second wave.<xref rid="gps5540-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> Subsequent analysis of the same population demonstrated that NPS emerged in advance of cognitive symptoms in 59% of dementia participants, including 30% of those who developed AD. For impulse dyscontrol symptoms, irritability emerged before dementia in 38% of cases (21% before MCI), agitation before dementia in 26% of cases (13% before MCI), and motor disturbance before dementia in 6% of cases (3% before MCI).<xref rid="gps5540-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> These symptoms of impulse dyscontrol are common in preclinical and prodromal disease, are associated with greater risk of incident cognitive decline and dementia and represent clinically significant symptoms often requiring pharmacological intervention. Further exploration of impulse dyscontrol is warranted.</p><p>Research has assessed neuroimaging correlates of agitation, aggression, and impulse dyscontrol in dementia but to a lesser extent in predementia groups. Agitation/aggression in MCI and AD has been associated with atrophy in fronto‐limbic regions, the right posterior cingulate, and left hippocampus.<xref rid="gps5540-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Aberrant motor behavior symptoms have been associated with atrophy in the right basal nuclei and frontal cortex.<xref rid="gps5540-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> Furthermore, reduced fractional anisotropy (FA) in the anterior cingulum<xref rid="gps5540-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> has been associated with agitation and irritability.</p><p>This present study focused on identifying the neuroanatomical correlates of impulse dyscontrol in older adults, outside of diagnostic and nosological boundaries. Increasing knowledge of the neural correlates of impulse dyscontrol may improve diagnosis, aid in disease prognostication, and identify potential treatment targets. The objective of this study was to assess white matter and volumetric parameters in a priori selected brain regions in association with symptoms of impulse dyscontrol in individuals with NC, MCI, and AD. Based on our literature review, the large white matter tracts assessed include the cingulum, fornix, superior fronto‐occipital fasciculus, inferior fronto‐occipital fasciculus, and the uncinate fasciculus (Figure <xref rid="gps5540-fig-0001" ref-type="fig">1</xref>
<xref rid="gps5540-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>). Volumetric analysis included the hippocampus, caudal and rostral anterior cingulate, amygdala, parahippocampal gyrus, and the medial orbitofrontal cortex (Figure <xref rid="gps5540-fig-0002" ref-type="fig">2</xref>
<xref rid="gps5540-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>). We hypothesized that symptoms of impulse dyscontrol would be associated with decreased white matter integrity in the cingulum and with atrophy patterns in fronto‐limbic structures.</p><fig position="float" fig-type="FIGURE" id="gps5540-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Visual representation of diffusion tensor imaging regions analyzed in association with impulse dyscontrol symptoms (A) profile view, (B) sagittal view, (C) coronal view</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="GPS-36-1398-g002.jpg"/></fig><fig position="float" fig-type="FIGURE" id="gps5540-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Visual representation of volumetric regions analyzed in association with impulse dyscontrol symptoms (A) profile view, (B) sagittal view, (C) coronal view</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="GPS-36-1398-g001.jpg"/></fig></sec><sec id="gps5540-sec-0020"><label>2</label><title>METHODS</title><sec id="gps5540-sec-0030"><label>2.1</label><title>Alzheimer's Disease Neuroimaging Initiative</title><p>Data was extracted from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://adni.loni.usc.edu/" ext-link-type="uri">http://adni.loni.usc.edu/</ext-link>). ADNI is a large, multi‐center longitudinal study that aims to track the progression of AD. We focused on participants within the ADNI‐GO/2 cohort because they had processed diffusion tensor imaging (DTI) and volumetric magnetic resonance imaging (MRI) data available. Participants met the general ADNI eligibility, inclusion and exclusion criteria. ADNI grouped participants into multiple diagnostic categories based on their clinical assessments (For further detail see: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://adni.loni.usc.edu/" ext-link-type="uri">http://adni.loni.usc.edu/</ext-link>).</p></sec><sec id="gps5540-sec-0040"><label>2.2</label><title>Data extraction</title><p>Demographic, clinical, and quantified structural MRI and DTI data were used for the analysis. To quantify symptoms of impulse dyscontrol, NPI questionnaire (NPI‐Q)<xref rid="gps5540-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> scores were also extracted. All datasets were downloaded before January 25, 2019.</p><p>To evaluate both white and gray matter regions associated with impulse dyscontrol, we included all participants that had baseline quantified DTI, MRI, and NPI‐Q data available. Participants were excluded for: (1) missing baseline DTI data; (2) missing NPI‐Q scores (i.e., no impulse dyscontrol score); (3) quantitative MRI analysis classified as “Fail” or “Hippocampus only” by visual quality control by the UCSF core lab; or (4) missing cognitive composite scores. Figure <xref rid="gps5540-fig-0001" ref-type="fig">1</xref> shows the step‐by‐step process of participants included/excluded from the analysis.</p></sec><sec id="gps5540-sec-0050"><label>2.3</label><title>Participants</title><p>A total of 203 participants were included for the analysis: <italic toggle="yes">n</italic> = 70 NC; <italic toggle="yes">n</italic> = 95 MCI; and <italic toggle="yes">n</italic> = 38 AD‐dementia.</p></sec><sec id="gps5540-sec-0060"><label>2.4</label><title>Measures</title><p>
<bold>Clinical variables</bold>. Age, sex, education, baseline diagnostic status, psychotropic medication use, and composite scores for memory and executive function were included as clinical features to investigate the potential relationships with neural correlates associated with impulse dyscontrol scores. Psychotropic medications included antidepressants, benzodiazepines, and z‐drugs. The diagnostic status was determined by clinical assessments at the time of visit. The cognitive composite scores were standardized scores calculated by transforming data collected through the ADNI neuropsychological battery into memory and executive functioning domains.<xref rid="gps5540-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>
</p><p>
<bold>Neuropsychiatric variables.</bold> Since ADNI uses the NPI‐Q to capture NPS, these data were transformed into MBI domains using a published algorithm.<xref rid="gps5540-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> NPI‐Q items were combined to form a composite MBI impulse domain score by adding NPI‐Q agitation/aggression, irritability, and aberrant motor behavior scores. The reference range for the NPI‐Q is 1 month, and thus the transformation algorithm generated an approximation for 1 month only. For the statistical analysis, impulse dyscontrol was classified as 0 or 1 to indicate the absence and presence of symptoms respectively.</p><p>
<bold>Neuroimaging variables.</bold> Quantified neuroimaging data were downloaded from ADNI. The output from processed diffusion‐tensor MRI and T1‐weighted images was used in the analyses. University of California Los Angeles (UCLA) core lab processed the DTI datasets, computing average FA, mean diffusivity (MD), axial diffusivity (AxD), and radial diffusivity (RD) values within regions of interests from the John Hopkins University DTI atlas. MD measures the molecular diffusion rate, FA measures the directional preference of water, RD and AxD measure the rate of diffusion along the transverse and main axis, respectively.<xref rid="gps5540-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> In a neurodegenerative disease, the typical pattern of DTI parameters is a decrease in FA, and an increase in MD, AxD, and RD indicative of neuronal tissue damage.<xref rid="gps5540-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> Additional information about the UCLA DTI methods are described in more detail elsewhere.<xref rid="gps5540-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> For the T1‐weighted images, UCSF core lab used FreeSurfer version 5.1 for cortical reconstruction and volumetric segmentation. Outputs included cortical thickness, surface area, and volumetric measurements within regions labeled by the 2010 Desikan‐Killany and 2009 Destrieux atlas. Additional information on UCSF FreeSurfer methods is also available elsewhere.<xref rid="gps5540-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> In order to control for intracranial volume (ICV) differences, we computed a normalization factor by averaging ICV of the whole sample and dividing it by individual ICV. This ratio was multiplied with all cortical and subcortical volume variables.<xref rid="gps5540-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>
</p><p>Figures <xref rid="gps5540-fig-0001" ref-type="fig">1</xref> and <xref rid="gps5540-fig-0002" ref-type="fig">2</xref> show the a priori selected brain regions in association with symptoms of impulse dyscontrol. The regions were labeled on the JHU atlas Desikan‐Killany atlas respectively. For details on the atlas see: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://neurovault.org/images/1401/" ext-link-type="uri">https://neurovault.org/images/1401/</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/XCCE9Q" ext-link-type="uri">https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/XCCE9Q</ext-link>).</p></sec><sec id="gps5540-sec-0070"><label>2.5</label><title>Statistical analysis</title><p>Sample characteristics are reported using means, standard deviations, and frequency distributions. Wilcoxon‐Mann‐Whitney tests were used to investigate univariate associations between patient characteristics and impulse dyscontrol symptoms. Linear mixed effect (LME) models were used to assess if impulse dyscontrol was associated with DTI parameters. White matter regions included in this analysis were the cingulum, cingulum (hippocampus), fornix, superior fronto‐occipital fasciculus, inferior fronto‐occipital fasciculus, and the uncinate fasciculus. Fixed effects included impulse dyscontrol, regions, impulse dyscontrol by regions, disease status, age, sex, psychotropic drug use, and education. Random effects included the hemisphere of the structure (left/right) and subjects. In the LME models, our primary predictors of interest were impulse dyscontrol, white matter regions, and impulse dyscontrol by regions. Similar analyses were conducted to test if impulse dyscontrol presence was related to volumetric measures, where regions included the hippocampus, caudal and rostral anterior cingulate, amygdala, parahippocampal gyrus, and the medial orbitofrontal cortex. Simple effect of MBI on the ROIs after LME modeling are reported. With seven different LME models in total (4 for DTI, 3 for volumetric measures), significance level was adjusted to 0.01 (instead of 0.05) to minimize inflation in type 1 error. The analyses were conducted in SAS v9.4.</p></sec></sec><sec id="gps5540-sec-0080"><label>3</label><title>RESULTS</title><p>Impulse dyscontrol (presence of any items in the impulse dyscontrol domain) was present in 17% of the individuals with NC, 43% with MCI, and 66% with AD. Table <xref rid="gps5540-tbl-0001" ref-type="table">1</xref> shows the demographic characteristics and cognitive test scores in individuals with or without symptoms of impulse dyscontrol. Across the impulse dyscontrol groups, there were no significant differences with the exception of diagnostic status (<italic toggle="yes">p</italic> &lt; 0.01), wherein worse cognitive diagnostic status was associated with the presence of impulse dyscontrol. Notably, there were more males with impulse dyscontrol symptoms than females. Additionally, there were more individuals with impulse dyscontrol symptoms that were using psychotropic medications.</p><table-wrap position="float" id="gps5540-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Demographic characteristics and cognitive test scores across groups</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"> </th><th align="left" valign="bottom" rowspan="1" colspan="1">Total sample (n = 203) </th><th align="left" valign="bottom" rowspan="1" colspan="1">Impulse dyscontrol symptoms absent (<italic toggle="yes">n</italic> = 123) </th><th align="left" valign="bottom" rowspan="1" colspan="1">Impulse dyscontrol symptoms present (<italic toggle="yes">n</italic> = 80) </th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>‐value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (<italic toggle="yes">M</italic>, SD) </td><td align="char" char="(" valign="top" rowspan="1" colspan="1">73.30 (6.67) </td><td align="char" char="(" valign="top" rowspan="1" colspan="1">73.30 (6.66) </td><td align="char" char="(" valign="top" rowspan="1" colspan="1">73.30 (6.75) </td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.59 </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education (<italic toggle="yes">M</italic>, SD) </td><td align="char" char="(" valign="top" rowspan="1" colspan="1">16.10 (2.71) </td><td align="char" char="(" valign="top" rowspan="1" colspan="1">16.10 (2.82) </td><td align="char" char="(" valign="top" rowspan="1" colspan="1">16.00 (2.56) </td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.74 </td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female (n, %) </td><td align="char" char="(" valign="top" rowspan="1" colspan="1">92 (45.32) </td><td align="char" char="(" valign="top" rowspan="1" colspan="1">64 (69.60) </td><td align="char" char="(" valign="top" rowspan="1" colspan="1">28 (30.40) </td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.021 </td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Diagnostic status (<italic toggle="yes">n</italic>, <italic toggle="yes">%</italic>)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">NC</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">70 (34.48)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">58 (82.86)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">12 (17.14)</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MCI</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">95 (46.80)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">52 (54.74)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">43 (45.26)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">AD</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">38 (18.72)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">13 (34.21)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">25 (65.79)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">ADNI_MEM (<italic toggle="yes">M</italic>, SD) </td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">NC</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.09 (0.62)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.03 (0.63)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.39 (0.45)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.04</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MCI</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.22 (0.59)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.21 (0.57)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.24 (0.62)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.97</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">AD</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−0.82 (0.48)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−0.86 (0.47)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−0.80 (0.49)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.63</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">ADNI_EF (<italic toggle="yes">M</italic>, SD)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">NC</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.87 (0.74)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.83 (0.77)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.04 (0.58)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.42</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MCI</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.17 (0.79)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.15 (0.74)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.18 (0.86)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.82</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">AD</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−0.87 (0.93)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−1.04 (1.05)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−0.79 (0.87)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.44</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Psychotropic medication use (n, %)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">52 (25.62)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">25 (20.33)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">27 (33.75)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.03</td></tr></tbody></table><table-wrap-foot id="gps5540-ntgp-0001"><fn id="gps5540-note-0002"><p>Abbreviations: AD, AD‐dementia; ADNI_EF, executive functioning composite score; ADNI_MEM, memory composite score; <italic toggle="yes">M</italic>, mean; MBI, mild behavioral impairment; MCI, mild cognitive impairment; NC, normal cognition; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap><sec id="gps5540-sec-0090"><label>3.1</label><title>Linear mixed effect models</title><p>DTI variables: After controlling for age, sex, education, disease status, and psychotropic drug use, participants with impulse dyscontrol had lower FA in the fornix (βFA = −0.02 SE = 5.1 × 10<sup>−3</sup>
<italic toggle="yes">p</italic> = 0.001) and lower FA in superior fronto‐occipital fasciculus (βFA = −0.01; SE = 4.7 × 10<sup>−3</sup>; <italic toggle="yes">p</italic> = 0.007) compared to those without. Significantly higher MD, AxD, and RD values were observed in the fornix (βMD = 0.18 × 10<sup>−3</sup> SE = 0.04 × 10<sup>−3</sup>
<italic toggle="yes">p</italic> &lt; 0.0001; βAxD = 0.16 × 10<sup>−3</sup> SE = 0.03×10<sup>−3</sup>
<italic toggle="yes">p</italic> &lt; 0.0001; βRD = 0.19 × 10<sup>−3</sup> SE = 0.04 × 10<sup>−3</sup>
<italic toggle="yes">p</italic> &lt; 0.0001, respectively), and superior fronto‐occipital fasciculus (βMD = 0.11 × 10‐3 SE = 0.03 × 10<sup>−3</sup>
<italic toggle="yes">p</italic> = 0003; βAxD = 0.12 × 10<sup>−3</sup> SE = 0.03 × 10<sup>−3</sup>
<italic toggle="yes">p</italic> &lt; 0.0001; βRD = 0.13 × 10<sup>−3</sup> SE = 0.03 × 10<sup>−3</sup>
<italic toggle="yes">p</italic> &lt; 0.0001, respectively) for patients with impulse dyscontrol. See Table <xref rid="gps5540-tbl-0002" ref-type="table">2</xref> for details.</p><table-wrap position="float" id="gps5540-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Simple effect of MBI on regions of interest for DTI parameters from linear mixed‐effects regression analysis controlling for age, sex, education, psychotropic medication use, and disease diagnosis (MCI, AD, or NC)</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom" colspan="1"/><th colspan="2" align="left" valign="bottom" rowspan="1">FA </th><th colspan="2" align="left" valign="bottom" rowspan="1">MD </th><th colspan="2" align="left" valign="bottom" rowspan="1">AxD </th><th colspan="2" align="left" valign="bottom" rowspan="1">RD </th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Estimate (SE)×10<sup>−3</sup>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Estimate (SE) × 10<sup>−3</sup>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p </italic>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Estimate (SE) × 10<sup>−3</sup>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Estimate (SE) ×10<sup>−3</sup>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">CGC  MBI + versus MBI ‐</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−0.75 (3.45)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.83</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">&lt;0.01 (0.01)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.887</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">&lt;0.01 (0.01)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.854</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.01 (0.02)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.609</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CGH  MBI + versus MBI ‐</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−0.09 (3.54)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.98</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.02 (0.02)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.178</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.03 (0.02)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.067</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.03 (0.02)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.153</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FX  MBI + versus MBI ‐</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−16.48 (5.08)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>0.001</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.18 (0.04)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>&lt;0.0001</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.16 (0.03)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>&lt;0.0001</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.19 (0.04)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>&lt;0.0001</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IFO  MBI + versus MBI ‐</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−0.64 (3.59)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.86</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">&lt;0.01 (0.02)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.794</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.01 (0.02)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.609</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.01 (0.02)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.480</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SFO  MBI + versus MBI ‐</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−12.88 (4.73)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>0.007</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.11 (0.03)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>0.0003</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.12 (0.03)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>&lt;0.0001</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.13 (0.03)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>&lt;0.0001</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UNC  MBI + versus MBI ‐</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2.48 (4.66)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.60</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.04 (0.02)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.068</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.05 (0.02)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.018</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.04 (0.02)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.043</td></tr></tbody></table><table-wrap-foot id="gps5540-ntgp-0002"><fn id="gps5540-note-0003"><p>Abbreviations: AD, AD‐dementia; AxD, axial diffusivity; CGC, cingulum; CGH, cingulum (hippocampus); F, female; FA, fractional anisotropy; FX, fornix; IFO, inferior fronto‐occipital fasciculus; M, male; MCI, mild cognitive impairment; MD, mean diffusivity; MBI+, presence of impulse dyscontrol symptoms; NC, normal cognition; RD, radial diffusivity; SFO, superior fronto‐occipital fasciculus; SE, standard error; UNC, uncinate fasciculus.</p></fn></table-wrap-foot></table-wrap><p>Volumetric variables: After controlling for age, sex, education, disease status, and psychotropic drug use, impulse dyscontrol symptoms were associated with participants having smaller cortical thickness in the parahippocampal gyrus (β = −0.1 SE = 0.04 <italic toggle="yes">p</italic> = 0.008). None of the other a priori selected regions were associated with impulse dyscontrol. See Table <xref rid="gps5540-tbl-0003" ref-type="table">3</xref> for details.</p><table-wrap position="float" id="gps5540-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>Simple effect of MBI on regions of interest for cortical thickness, surface area, and volume from linear mixed‐effects regression analysis controlling for age, sex, education, psychotropic medication use, and disease diagnosis (MCI, AD, or NC)</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom" colspan="1"/><th colspan="2" align="left" valign="bottom" rowspan="1">Cortical Thickness (mm)</th><th colspan="2" align="left" valign="bottom" rowspan="1">Surface Area (mm<sup>2</sup>) </th><th colspan="2" align="left" valign="bottom" rowspan="1">Volume (mm<sup>3</sup>)</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Estimate (SE)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Estimate (SE)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Estimate (SE)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Caudal anterior Cingulate MBI + versus MBI−</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.05 (0.04)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.206</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−6.97 (13.90)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.616</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">30.92 (50.78)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.543</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Medial Orbitofrontal MBI + versus MBI−</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.05 (0.02)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.031</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">15.96 (20.66)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.440</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">84.27 (56.39)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.135</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Parahippocampal gyrus MBI + versus MBI−</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−0.10 (0.04)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">
<bold>0.008</bold>
</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">21.98 (12.42)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.077</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">43.86 (37.28)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.240</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Amygdala MBI + versus MBI−</td><td align="left" valign="top" rowspan="1" colspan="1">‐</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">‐</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="(" valign="top" rowspan="1" colspan="1">−6.74 (28.97)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.816</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hippocampus MBI + versus MBI−</td><td align="left" valign="top" rowspan="1" colspan="1">‐</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">‐</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" char="(" valign="top" rowspan="1" colspan="1">−125.81 (52.53)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rostral anterior cingulate MBI + versus MBI−</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.03 (0.03)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.309</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">−15.08 (14.74)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.306</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.91 (47.97)</td><td align="char" char="." valign="top" rowspan="1" colspan="1">0.985</td></tr></tbody></table><table-wrap-foot id="gps5540-ntgp-0003"><fn id="gps5540-note-0004"><p>Abbreviations: MBI+, presence of MBI impulse dyscontrol symptoms; SE, standard error.</p></fn></table-wrap-foot></table-wrap><p>Additional results from the modeling are available in Table <xref rid="gps5540-sup-0001" ref-type="supplementary-material">S1 to S4</xref>.</p></sec></sec><sec id="gps5540-sec-0100"><label>4</label><title>DISCUSSION</title><p>In this study, the relationship between structural neuroimaging markers and impulse dyscontrol symptoms was explored across cognitive categories. In those with NC, MCI, and AD, both white and gray matter differences were identified in individuals with impulse dyscontrol emphasizing the importance of these symptoms in neurodegenerative disease and supporting the notion of behavioral sequelae of brain structural changes across the cognitive spectrum.</p><p>In interpreting DTI parameters, reduced FA and increased MD, AxD, and RD are associated with impaired white matter integrity as an outcome of several factors including cell death and altered myelination, amongst others.<xref rid="gps5540-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="gps5540-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> In this study, as shown by the altered DTI parameters, lower white matter integrity in tracts including the cingulum, fornix, superior fronto‐occipital fasciculus, and uncinate fasciculus was associated with impulse dyscontrol. To our knowledge, Tighe et al.<xref rid="gps5540-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> published the only DTI study to date that reported lower FA of the anterior cingulum to be associated with symptoms of agitation and irritability. While differences in the FA of the cingulum were not significant in our study, the cingulum was still implicated with greater AxD in individuals with impulse dyscontrol symptoms. The cingulum is an important tract that connects frontal, parietal, and medial temporal regions, including several limbic structures, and microstructural changes in this tract have been associated with MCI and AD.<xref rid="gps5540-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> Furthermore, a recent study identified altered DTI parameters in the cingulum in early‐stage AD.<xref rid="gps5540-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> In another ADNI study of participants with preclinical AD (amyloid and tau positive), irritability predicted hypometabolism in the posterior cingulate cortex 2 years later, supporting the role of irritability as a preclinical AD marker.<xref rid="gps5540-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> Our study extends the evidence base for the cingulum as a potential early neuroimaging marker, which can show changes in DTI parameters in individuals with impulse dyscontrol symptoms in advance of dementia.</p><p>With significant differences in all diffusion parameters, the fornix was another important tract that was associated with symptoms of impulse dyscontrol. The relationship of the fornix and NPSs in pre‐dementia and dementia populations is largely unexplored. However, there is evidence supporting neurodegeneration in the fornix predicting degree of memory impairment and the likelihood of progression to AD.<xref rid="gps5540-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>, <xref rid="gps5540-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> A reduced fornix FA is one of the earliest MRI abnormalities observed in individuals at risk of AD<xref rid="gps5540-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> and has been explored as a treatment target using deep brain stimulation for mild AD.<xref rid="gps5540-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref> In a recent study, damaged white matter integrity of the fornix was also associated with reduced resting‐state functional connectivity of the hippocampus in individuals with MCI and AD.<xref rid="gps5540-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref> Observing fornix impairment in association with impulse dyscontrol highlights NPSs as part of the early disease process. The cingulum, fornix, and fronto‐occipital fasciculus tracts are all important for connections between hippocampus to the hypothalamus and connecting orbitofrontal areas to the occipital regions. These white matter differences combined with gray matter atrophy in the parahippocampal gyrus provide evidence that the well‐established atrophy patterns in AD<xref rid="gps5540-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>, <xref rid="gps5540-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref> are also prominent in the presence of behavioral symptoms, even after adjustment for disease status.</p><p>These findings also suggest that white matter damage is more prominent than gray matter atrophy, in line with past literature, which has determined that microstructural white matter changes precede gray matter atrophy.<xref rid="gps5540-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> With the goal to identify the neural correlates associated with the MBI impulse dyscontrol domain, the results suggest that the fronto‐striatal network plays a key role in regulating these behaviors. Rosenberg et al.<xref rid="gps5540-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref> identified that the agitation circuit consists of the frontal cortex, anterior cingulate cortex, orbitofrontal cortex, amygdala, hippocampus, and insula. Since these regions associated with agitation mapped onto the salience network, the authors proposed that increased connectivity within this network could explain agitation in individuals. Similarly, we observed the cingulum, fronto‐occipital tracts, fornix, uncinate fasciculus, and parahippocampal gyrus as key regions associated with impulse dyscontrol. Some of the regions from this study also overlap with the agitation circuits previously identified<xref rid="gps5540-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref> providing evidence of brain changes similar to core AD pathology, which can precede cognitive symptoms or dementia.</p><p>Beyond differences in neural correlates, we also observed group differences in the sex of the participants in our study. More men had symptoms of impulse dyscontrol present. There is some evidence that suggests males have greater impulse control behaviors,<xref rid="gps5540-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> however, other studies have identified NPS such as, disinhibition, verbal aggression, and irritability to be more common in females.<xref rid="gps5540-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref>, <xref rid="gps5540-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref>, <xref rid="gps5540-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref> These differences across studies could be an outcome of variations based on recruitment strategy, study design, sample analyzed, diagnostic criteria, and the instruments used to measure NPS. The higher proportion of males with impulse dyscontrol symptoms adds to the evidence base. However, further research is required explore sex differences in association with NPS.</p><p>There are several strengths of this study. For example, this is one of the first studies to explore neural correlates of the MBI impulse dyscontrol domain in a majority of predementia participants. Being a relatively new syndrome, understanding the biological changes associated with MBI domains can help clinicians and researchers appreciate the neural underpinnings of later life behavioral changes, and link these to dementia risk. Additionally, our sample primarily consisted of individuals in the preclinical and prodromal stages of AD‐dementia—identifying patterns of micro/macro‐structural changes at earlier stages could support future prediction models and enable early patient identification.</p><p>There are some limitations of this study. MBI case detection was approximated using transformations of the NPI‐Q. Since NPI‐Q measures symptoms within 1‐month range, it is possible that we captured transient symptoms that may have resolved, thus decreasing diagnostic specificity. Studies have shown inflated MBI prevalence using transformed scores<xref rid="gps5540-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="gps5540-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> in comparison to the use of the MBI checklist (MBI‐C), which is the validated a priori case ascertainment instrument developed for MBI.<xref rid="gps5540-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref> The MBI‐C has demonstrated ability to serve as a proxy marker for older adults with subtle cognitive changes or early neurodegenerative disease.<xref rid="gps5540-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="gps5540-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref> Thus, diagnostic sensitivity of this approach may also be a limitation, as the whole breadth of MBI impulse dyscontrol, validated by network meta‐analysis<xref rid="gps5540-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref> is not captured by the NPI‐Q. Future studies that use MBI‐C should further investigate the neural correlates associated with MBI impulse dyscontrol and other domains to verify our results. Additionally, ADNI excludes patients with psychiatric illness (some of which may actually be prodromal dementia symptoms)<xref rid="gps5540-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> or those with severe NPS. Thus, the sample included in this study might underappreciate the extent of NPS in the preclinical and prodromal population. Other datasets should be explored for further validation of our results.</p></sec><sec id="gps5540-sec-0110"><label>5</label><title>CONCLUSIONS</title><p>To our knowledge, this is one of the first few studies that explores the neural correlates of impulse dyscontrol in predementia participants. We demonstrate typical AD structural changes in the brain associated with these behavioral symptoms, even in advance of dementia or cognitive decline, emphasizing the utility of assessing behavior. Understanding the neuropsychiatric manifestations of the neurodegenerative disease can help clinicians in predicting the progression of the disease.</p></sec><sec sec-type="COI-statement" id="gps5540-sec-0130"><title>CONFLICT OF INTEREST</title><p>Dr. Ismail reports consultation fees and honoraria from Janssen, Lundbeck, and Otsuka, outside the submitted work; Dr. Smith reports personal fees from Alnylman Pharmaceuticals and Biogen, outside the submitted work; no other authors have financial interests with commercial interests.</p></sec><sec id="gps5540-sec-0140"><title>ETHICS STATEMENT</title><p>The ADNI study was approved by all the Institutional Ethical Review Boards of all participating centers. All participants signed written informed consent.</p></sec><sec sec-type="COI-statement" id="gps5540-sec-0150"><title>AUTHORS' CONTRIBUTIONS</title><p>SG analyzed and interpreted the data and contributed in writing the manuscript. PM, MW, DR, and TS were involved in the statistical analyses. FPM, EES, NDF, and ZI critically analyzed the results and made intellectual contributions to writing the manuscript. All authors read and approved the final manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="gps5540-sup-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>Supplementary Material</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="GPS-36-1398-s001.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="gps5540-sec-0120"><title>ACKNOWLEDGEMENTS</title><p>Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH‐12‐2‐0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol‐Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann‐La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research &amp; Development, LLC.; Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC.; Lumosity; Lundbeck; Merck &amp; Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. Alzheimer Society of Calgary via the Hotchkiss Brain Institute—University of Calgary.</p></ack><sec sec-type="data-availability" id="gps5540-sec-0170"><title>DATA AVAILABILITY STATEMENT</title><p>The datasets used and/or analyzed during the current study are available through the open access ADNI database.</p></sec><ref-list content-type="cited-references" id="gps5540-bibl-0001"><title>REFERENCES</title><ref id="gps5540-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="gps5540-cit-0001"><string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Geda</surname><given-names>Y</given-names></string-name>, et al. <article-title>Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment</article-title>. <source>Alzheimer's Dementia</source>. <year>2016</year>;<volume>12</volume>(<issue>2</issue>):<fpage>195</fpage>‐<lpage>202</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jalz.2015.05.017</pub-id><pub-id pub-id-type="pmcid">PMC4684483</pub-id><pub-id pub-id-type="pmid">26096665</pub-id></mixed-citation></ref><ref id="gps5540-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="gps5540-cit-0002"><string-name name-style="western"><surname>Creese</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Griffiths</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Brooker</surname><given-names>H</given-names></string-name>, et al. <article-title>Profile of mild behavioral impairment and factor structure of the mild behavioral impairment checklist in cognitively normal older adults</article-title>. <source>Int Psychogeriatr</source>. <year>2020</year>;<volume>32</volume>(<issue>6</issue>):<fpage>705</fpage>‐<lpage>717</lpage>.<pub-id pub-id-type="pmid">31526407</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1041610219001200</pub-id></mixed-citation></ref><ref id="gps5540-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="gps5540-cit-0003"><string-name name-style="western"><surname>Creese</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Brooker</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, et al. <article-title>Mild behavioral impairment as a marker of cognitive decline in cognitively normal older adults</article-title>. <source>Am J Geriatric Psychiatry</source>. <year>2019</year>;<volume>27</volume>(<issue>8</issue>):<fpage>823</fpage>‐<lpage>834</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jagp.2019.01.215</pub-id><pub-id pub-id-type="pmid">30902566</pub-id></mixed-citation></ref><ref id="gps5540-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="gps5540-cit-0004"><string-name name-style="western"><surname>Mallo</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Pereiro</surname><given-names>AX</given-names></string-name>, et al. <article-title>Assessing mild behavioral impairment with the mild behavioral impairment‐checklist in people with mild cognitive impairment</article-title>. <source>J Alzheimer's Dis</source>. <year>2018</year>;<volume>66</volume>(<issue>1</issue>):<fpage>83</fpage>‐<lpage>95</lpage>.<pub-id pub-id-type="pmid">30175974</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-180131</pub-id></mixed-citation></ref><ref id="gps5540-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="gps5540-cit-0005"><string-name name-style="western"><surname>Mallo</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Pereiro</surname><given-names>AX</given-names></string-name>, et al. <article-title>Assessing mild behavioral impairment with the mild behavioral impairment checklist in people with subjective cognitive decline</article-title>. <source>Int Psychogeriatr</source>. <year>2018</year>:<fpage>1</fpage>‐<lpage>9</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1041610218000698</pub-id><pub-id pub-id-type="pmid">30017017</pub-id></mixed-citation></ref><ref id="gps5540-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="gps5540-cit-0006"><string-name name-style="western"><surname>Matsuoka</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Narumoto</surname><given-names>J</given-names></string-name>. <article-title>Prevalence of mild behavioral impairment and risk of dementia in a psychiatric outpatient clinic</article-title>. <source>J Alzheimer's Dis</source>. <year>2019</year>;<volume>70</volume>(<issue>2</issue>):<fpage>505</fpage>‐<lpage>513</lpage>.<pub-id pub-id-type="pmid">31177229</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-190278</pub-id><pub-id pub-id-type="pmcid">PMC6700628</pub-id></mixed-citation></ref><ref id="gps5540-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="gps5540-cit-0007"><string-name name-style="western"><surname>Taragano</surname><given-names>FE</given-names></string-name>, <string-name name-style="western"><surname>Allegri</surname><given-names>RF</given-names></string-name>, <string-name name-style="western"><surname>Heisecke</surname><given-names>SL</given-names></string-name>, et al. <article-title>Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment group</article-title>. <source>J Alzheimer's Dis</source>. <year>2018</year>;<volume>62</volume>(<issue>1</issue>):<fpage>227</fpage>‐<lpage>238</lpage>.<pub-id pub-id-type="pmid">29439333</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-170632</pub-id></mixed-citation></ref><ref id="gps5540-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="gps5540-cit-0008"><string-name name-style="western"><surname>Gosselin</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Faris</surname><given-names>PD</given-names></string-name>, et al. <article-title>Effect of hearing ability and mild behavioural impairment on MoCA and memory index scores</article-title>. <source>Can Geri J</source>. <year>2019</year>;<volume>22</volume>(<issue>3</issue>):<fpage>165</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.5770/cgj.22.374</pub-id><pub-id pub-id-type="pmcid">PMC6715413</pub-id><pub-id pub-id-type="pmid">31565112</pub-id></mixed-citation></ref><ref id="gps5540-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="gps5540-cit-0009"><string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>McGirr</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gill</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Forkert</surname><given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>EE</given-names></string-name>. <article-title>Mild behavioral impairment and subjective cognitive decline predict cognitive and functional decline</article-title>. <source>J Alzheimers Dis</source>. <year>2021</year>. in press. <volume>80</volume>(<issue>1</issue>):<fpage>459</fpage>–<lpage>469</lpage>. <pub-id pub-id-type="doi">10.3233/jad-201184</pub-id><pub-id pub-id-type="pmid">33554909</pub-id><pub-id pub-id-type="pmcid">PMC8075401</pub-id></mixed-citation></ref><ref id="gps5540-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="gps5540-cit-0010"><string-name name-style="western"><surname>Gill</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mouches</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>S</given-names></string-name>, et al. <article-title>Using machine learning to predict dementia from neuropsychiatric symptom and neuroimaging data</article-title>. <source>J Alzheimer's Dis</source>. <year>2020</year>;<volume>75</volume>(<issue>1</issue>):<fpage>277</fpage>‐<lpage>288</lpage>.<pub-id pub-id-type="pmid">32250302</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-191169</pub-id><pub-id pub-id-type="pmcid">PMC7306896</pub-id></mixed-citation></ref><ref id="gps5540-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="gps5540-cit-0011"><string-name name-style="western"><surname>Lussier</surname><given-names>FZ</given-names></string-name>, <string-name name-style="western"><surname>Pascoal</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Chamoun</surname><given-names>M</given-names></string-name>, et al. <article-title>Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals</article-title>. <source>Alzheimer's Dementia</source>. <year>2020</year>;<volume>16</volume>:<fpage>192</fpage>‐<lpage>199</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/alz.12007</pub-id><pub-id pub-id-type="pmcid">PMC7041633</pub-id><pub-id pub-id-type="pmid">31914223</pub-id></mixed-citation></ref><ref id="gps5540-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="gps5540-cit-0012"><string-name name-style="western"><surname>Johansson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Stomrud</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Insel</surname><given-names>P</given-names></string-name>, et al. <article-title>Mild Behavioral Impairment and its relation to tau pathology in preclinical Alzheimer’s disease</article-title>. <source>Transl Psychiatry</source>. <year>2021</year>;<volume>11</volume>(<issue>76</issue>).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41398-021-01206-z</pub-id><pub-id pub-id-type="pmcid">PMC7838407</pub-id><pub-id pub-id-type="pmid">33500386</pub-id></mixed-citation></ref><ref id="gps5540-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="gps5540-cit-0013"><person-group person-group-type="editor"><string-name name-style="western"><surname>Lussier</surname><given-names>FZ</given-names></string-name></person-group>, <person-group person-group-type="editor"><string-name name-style="western"><surname>Pascoal</surname><given-names>TA</given-names></string-name></person-group>, <person-group person-group-type="editor"><string-name name-style="western"><surname>Therriault</surname><given-names>J</given-names></string-name></person-group>, et al. <article-title>Mild behavioral impairment is associated with beta‐amyloid and tau across the alzheimer's disease spectrum</article-title>. <source>J Cereb Blood Flow Metab</source>. <year>2019</year>;<volume>39</volume>:<fpage>158</fpage>‐<lpage>159</lpage>.</mixed-citation></ref><ref id="gps5540-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="gps5540-cit-0014"><string-name name-style="western"><surname>Naude</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Gill</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>S</given-names></string-name>, et al. <article-title>Plasma neurofilament light: a marker of neurodegeneration in mild behavioral impairment</article-title>. <source>J Alzheimer's Dis</source>. <year>2020</year>;<volume>76</volume>(<issue>3</issue>):<fpage>1017</fpage>‐<lpage>1027</lpage>.<pub-id pub-id-type="pmid">32597801</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-200011</pub-id><pub-id pub-id-type="pmcid">PMC7504997</pub-id></mixed-citation></ref><ref id="gps5540-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="gps5540-cit-0015"><string-name name-style="western"><surname>Matuskova</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Nikolai</surname><given-names>T</given-names></string-name>, et al. <article-title>Mild behavioral impairment is associated with atrophy in Alzheimer's disease‐related regions in non‐demented older adults</article-title>. <source>Alzheimer's &amp; Dementia</source>. <year>2020</year>;<volume>16</volume>:<elocation-id>e044819</elocation-id>.</mixed-citation></ref><ref id="gps5540-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="gps5540-cit-0016"><string-name name-style="western"><surname>Yoon</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Hanganu</surname><given-names>A</given-names></string-name>, et al. <article-title>Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease</article-title>. <source>Neurology</source>. <year>2019</year>;<volume>93</volume>(<issue>8</issue>):<fpage>e766</fpage>‐<lpage>e777</lpage>.<pub-id pub-id-type="pmid">31320470</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000007968</pub-id><pub-id pub-id-type="pmcid">PMC6711660</pub-id></mixed-citation></ref><ref id="gps5540-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="gps5540-cit-0017"><string-name name-style="western"><surname>Andrews</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Anstey</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Mortby</surname><given-names>M</given-names></string-name>. <article-title>Association of Alzheimer's genetic loci with mild behavioral impairment</article-title>. <source>Am J Med Genet</source>. <year>2018</year>;<volume>177</volume>(<issue>8</issue>):<fpage>727</fpage>‐<lpage>735</lpage>.<pub-id pub-id-type="pmid">30378268</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ajmg.b.32684</pub-id></mixed-citation></ref><ref id="gps5540-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="gps5540-cit-0018"><string-name name-style="western"><surname>Lanctôt</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Amatniek</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ancoli‐Israel</surname><given-names>S</given-names></string-name>, et al. <article-title>Neuropsychiatric signs and symptoms of Alzheimer's disease: new treatment paradigms</article-title>. <source>Alzheimers Dement (N Y)</source>. <year>2017</year>;<volume>3</volume>:<fpage>440</fpage>‐<lpage>449</lpage>.<pub-id pub-id-type="pmid">29067350</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.trci.2017.07.001</pub-id><pub-id pub-id-type="pmcid">PMC5651439</pub-id></mixed-citation></ref><ref id="gps5540-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="gps5540-cit-0019"><string-name name-style="western"><surname>Fischer</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Schweizer</surname><given-names>TA</given-names></string-name>. <article-title>Impact of neuropsychiatric symptoms on caregiver burden in patients with Alzheimer's disease</article-title>. <source>Neurodegener Dis Manag</source>. <year>2012</year>;<volume>2</volume>(<issue>3</issue>):<fpage>269</fpage>‐<lpage>277</lpage>.</mixed-citation></ref><ref id="gps5540-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="gps5540-cit-0020"><string-name name-style="western"><surname>Mortby</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Anstey</surname><given-names>KJ</given-names></string-name>. <article-title>Prevalence estimates of mild behavioral impairment in a population‐based sample of pre‐dementia states and cognitively healthy older adults</article-title>. <source>Int Psychogeriatr</source>. <year>2018</year>;<volume>30</volume>(<issue>2</issue>):<fpage>221</fpage>‐<lpage>232</lpage>.<pub-id pub-id-type="pmid">28931446</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1041610217001909</pub-id></mixed-citation></ref><ref id="gps5540-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="gps5540-cit-0021"><string-name name-style="western"><surname>Sheikh</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Mortby</surname><given-names>ME</given-names></string-name>, et al. <article-title>Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden</article-title>. <source>Int Psychogeriatr</source>. <year>2018</year>;<volume>30</volume>:<fpage>233</fpage>‐<lpage>244</lpage>.<pub-id pub-id-type="pmid">28879833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S104161021700151X</pub-id></mixed-citation></ref><ref id="gps5540-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="gps5540-cit-0022"><string-name name-style="western"><surname>Masters</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Morris</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Roe</surname><given-names>CM</given-names></string-name>. <article-title>“Noncognitive” symptoms of early Alzheimer disease A longitudinal analysis</article-title>. <source>Neurology</source>. <year>2015</year>;<volume>84</volume>:<fpage>1</fpage>‐<lpage>6</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000001238</pub-id><pub-id pub-id-type="pmcid">PMC4335988</pub-id><pub-id pub-id-type="pmid">25589671</pub-id></mixed-citation></ref><ref id="gps5540-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="gps5540-cit-0023"><string-name name-style="western"><surname>Wise</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Rosenberg</surname><given-names>PB</given-names></string-name>, <string-name name-style="western"><surname>Lyketsos</surname><given-names>CG</given-names></string-name>, <string-name name-style="western"><surname>Leoutsakos</surname><given-names>JM</given-names></string-name>. <article-title>Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers</article-title>. <source>Alzheimer's Dement Diag, Assess Dis Monit</source>. <year>2019</year>;<volume>11</volume>:<fpage>333</fpage>‐<lpage>339</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dadm.2019.02.006</pub-id><pub-id pub-id-type="pmcid">PMC6476801</pub-id><pub-id pub-id-type="pmid">31024987</pub-id></mixed-citation></ref><ref id="gps5540-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="gps5540-cit-0024"><string-name name-style="western"><surname>Trzepacz</surname><given-names>PT</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Bhamidipati</surname><given-names>PK</given-names></string-name>, et al. <article-title>Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease</article-title>. <source>Alzheimer's Dementia</source>. <year>2013</year>;<volume>9</volume>(<issue>5 Suppl</issue>):<fpage>S95</fpage>‐<lpage>S104</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jalz.2012.10.005</pub-id><pub-id pub-id-type="pmcid">PMC3955297</pub-id><pub-id pub-id-type="pmid">23253778</pub-id></mixed-citation></ref><ref id="gps5540-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="gps5540-cit-0025"><string-name name-style="western"><surname>Hu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Meiberth</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Newport</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Jessen</surname><given-names>F</given-names></string-name>. <article-title>Anatomical correlates of the neuropsychiatric symptoms in Alzheimer's disease</article-title>. <source>Curr Alzheimer Res</source>. <year>2015</year>;<volume>12</volume>(<issue>3</issue>):<fpage>266</fpage>‐<lpage>277</lpage>.<pub-id pub-id-type="pmid">25731626</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1567205012666150302154914</pub-id></mixed-citation></ref><ref id="gps5540-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="gps5540-cit-0026"><string-name name-style="western"><surname>Tighe</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Oishi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Mori</surname><given-names>S</given-names></string-name>, et al. <article-title>Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia</article-title>. <source>J Neuropsychiatry Clin Neurosci</source>. <year>2012</year>;<volume>24</volume>(<issue>4</issue>):<fpage>484</fpage>‐<lpage>488</lpage>.<pub-id pub-id-type="pmid">23224456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/appi.neuropsych.11120375</pub-id><pub-id pub-id-type="pmcid">PMC3533244</pub-id></mixed-citation></ref><ref id="gps5540-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="gps5540-cit-0027"><string-name name-style="western"><surname>Pievani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Agosta</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Pagani</surname><given-names>E</given-names></string-name>, et al. <article-title>Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease</article-title>. <source>Hum Brain Mapp</source>. <year>2010</year>;<volume>31</volume>(<issue>12</issue>):<fpage>1862</fpage>‐<lpage>1875</lpage>.<pub-id pub-id-type="pmid">20162601</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hbm.20978</pub-id><pub-id pub-id-type="pmcid">PMC6870900</pub-id></mixed-citation></ref><ref id="gps5540-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="gps5540-cit-0028"><string-name name-style="western"><surname>Bateman</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Gill</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>S</given-names></string-name>, et al. <article-title>Agitation and impulsivity in mid and late life as possible risk markers for incident dementia</article-title>. <source>Alzheimer's Dementia Translational Research &amp; Clinical Interventions</source>. <year>2020</year>;<volume>6</volume>(<issue>1</issue>):<elocation-id>e12016</elocation-id>.<pub-id pub-id-type="pmid">32995467</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/trc2.12016</pub-id><pub-id pub-id-type="pmcid">PMC7507499</pub-id></mixed-citation></ref><ref id="gps5540-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="gps5540-cit-0029"><string-name name-style="western"><surname>Kaufer</surname><given-names>DI</given-names></string-name>, <string-name name-style="western"><surname>Cummings</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Ketchel</surname><given-names>P</given-names></string-name>, et al. <article-title>Validation of the NPI‐Q, a brief clinical form of the Neuropsychiatric Inventory</article-title>. <source>Jnp</source>. <year>2000</year>;<volume>12</volume>(<issue>2</issue>):<fpage>233</fpage>‐<lpage>239</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/jnp.12.2.233</pub-id><pub-id pub-id-type="pmid">11001602</pub-id></mixed-citation></ref><ref id="gps5540-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="gps5540-cit-0030"><string-name name-style="western"><surname>Gibbons</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Carle</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Mackin</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Harvey</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Mukherjee</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Insel</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Curtis</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Mungas</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Crane</surname><given-names>PK</given-names></string-name>, et al. <article-title>A composite score for executive functioning, validated in Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment</article-title>. <source>Brain imaging and behavior</source>. <year>2012</year>;<volume>6</volume>(<issue>4</issue>):<fpage>517</fpage>‐<lpage>527</lpage>.<pub-id pub-id-type="pmid">22644789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11682-012-9176-1</pub-id><pub-id pub-id-type="pmcid">PMC3684181</pub-id></mixed-citation></ref><ref id="gps5540-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="gps5540-cit-0031"><string-name name-style="western"><surname>Soares</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Marques</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Alves</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Sousa</surname><given-names>N</given-names></string-name>. <article-title>A hitchhiker's guide to diffusion tensor imaging</article-title>. <source>Front Neurosci</source>. <year>2013</year>;<volume>7</volume>:<fpage>31</fpage>.<pub-id pub-id-type="pmid">23486659</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnins.2013.00031</pub-id><pub-id pub-id-type="pmcid">PMC3594764</pub-id></mixed-citation></ref><ref id="gps5540-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="gps5540-cit-0032"><string-name name-style="western"><surname>Talai</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Sedlacik</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Boelmans</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Forkert</surname><given-names>ND</given-names></string-name>. <article-title>Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy</article-title>. <source>NeuroImage Clinic</source>. <year>2018</year>;<volume>20</volume>:<fpage>1037</fpage>‐<lpage>1043</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nicl.2018.09.028</pub-id><pub-id pub-id-type="pmcid">PMC6197764</pub-id><pub-id pub-id-type="pmid">30342392</pub-id></mixed-citation></ref><ref id="gps5540-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="gps5540-cit-0033"><string-name name-style="western"><surname>Nir</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Jahanshad</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Villalon‐Reina</surname><given-names>JE</given-names></string-name>, et al. <article-title>Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging</article-title>. <source>NeuroImage Clinic</source>. <year>2013</year>;<volume>3</volume>:<fpage>180</fpage>‐<lpage>195</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nicl.2013.07.006</pub-id><pub-id pub-id-type="pmcid">PMC3792746</pub-id><pub-id pub-id-type="pmid">24179862</pub-id></mixed-citation></ref><ref id="gps5540-bib-0034"><label>34</label><mixed-citation publication-type="book" id="gps5540-cit-0034"><string-name name-style="western"><surname>Hartig</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Truran‐Sacrey</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Raptentsetsang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Simonson</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mezher</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Schuff</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Weiner</surname><given-names>M</given-names></string-name>, et al. <source>UCSF FreeSurfer Methods</source>; <publisher-loc>San Francisco</publisher-loc>: <publisher-name>ADNI Alzheimers Disease Neuroimaging Initiative</publisher-name>; <year>2014</year>.</mixed-citation></ref><ref id="gps5540-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="gps5540-cit-0035"><string-name name-style="western"><surname>Talai</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Sedlacik</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Boelmans</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Forkert</surname><given-names>ND</given-names></string-name>. <article-title>Improved automatic morphology‐based classification of Parkinson’s disease and progressive supranuclear palsy</article-title>. <source>Clin Neuroradiol</source>. <year>2019</year>;<volume>29</volume>(<issue>4</issue>):<fpage>605</fpage>‐<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1007/s00062-018-0727-8</pub-id>.<pub-id pub-id-type="pmid">30218110</pub-id></mixed-citation></ref><ref id="gps5540-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="gps5540-cit-0036"><string-name name-style="western"><surname>O’Donnell</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Westin</surname><given-names>C‐F</given-names></string-name>. <article-title>An introduction to diffusion tensor image analysis</article-title>. <source>Neurosurgery Clinics</source>. <year>2011</year>;<volume>22</volume>(<issue>2</issue>):<fpage>185</fpage>‐<lpage>196</lpage>.<pub-id pub-id-type="pmid">21435570</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nec.2010.12.004</pub-id><pub-id pub-id-type="pmcid">PMC3163395</pub-id></mixed-citation></ref><ref id="gps5540-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="gps5540-cit-0037"><string-name name-style="western"><surname>Bubb</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Metzler‐Baddeley</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Aggleton</surname><given-names>JP</given-names></string-name>. <article-title>The cingulum bundle: anatomy, function, and dysfunction</article-title>. <source>Neurosci Biobehav Rev</source>. <year>2018</year>;<volume>92</volume>:<fpage>104</fpage>‐<lpage>127</lpage>.<pub-id pub-id-type="pmid">29753752</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neubiorev.2018.05.008</pub-id><pub-id pub-id-type="pmcid">PMC6090091</pub-id></mixed-citation></ref><ref id="gps5540-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="gps5540-cit-0038"><string-name name-style="western"><surname>Wen</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Mustafi</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, et al. <article-title>White matter alterations in early‐stage Alzheimer's disease: a tract‐specific study</article-title>. <source>Alzheimer's Dement Diag, Assess Dis Monit</source>. <year>2019</year>;<volume>11</volume>:<fpage>576</fpage>‐<lpage>587</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dadm.2019.06.003</pub-id><pub-id pub-id-type="pmcid">PMC6713788</pub-id><pub-id pub-id-type="pmid">31467968</pub-id></mixed-citation></ref><ref id="gps5540-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="gps5540-cit-0039"><string-name name-style="western"><surname>Ng</surname><given-names>KP</given-names></string-name>, <string-name name-style="western"><surname>Pascoal</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Mathotaarachchi</surname><given-names>S</given-names></string-name>, et al. <article-title>Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease</article-title>. <source>Neurology</source>. <year>2017</year>;<volume>88</volume>(<issue>19</issue>):<fpage>1814</fpage>‐<lpage>1821</lpage>.<pub-id pub-id-type="pmid">28404803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000003916</pub-id><pub-id pub-id-type="pmcid">PMC5419982</pub-id></mixed-citation></ref><ref id="gps5540-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="gps5540-cit-0040"><string-name name-style="western"><surname>Oishi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lyketsos</surname><given-names>CG</given-names></string-name>. <article-title>Alzheimer’s disease and the fornix</article-title>. <source>Front Aging Neurosci</source>. <year>2014</year>;<volume>6</volume>:<fpage>241</fpage>.<pub-id pub-id-type="pmid">25309426</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnagi.2014.00241</pub-id><pub-id pub-id-type="pmcid">PMC4161001</pub-id></mixed-citation></ref><ref id="gps5540-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="gps5540-cit-0041"><string-name name-style="western"><surname>Mielke</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Okonkwo</surname><given-names>OC</given-names></string-name>, <string-name name-style="western"><surname>Oishi</surname><given-names>K</given-names></string-name>, et al. <article-title>Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease</article-title>. <source>Alzheimer's Dementia</source>. <year>2012</year>;<volume>8</volume>(<issue>2</issue>):<fpage>105</fpage>‐<lpage>113</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jalz.2011.05.2416</pub-id><pub-id pub-id-type="pmcid">PMC3305232</pub-id><pub-id pub-id-type="pmid">22404852</pub-id></mixed-citation></ref><ref id="gps5540-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="gps5540-cit-0042"><string-name name-style="western"><surname>Kantarci</surname><given-names>K</given-names></string-name>. <article-title>Fractional anisotropy of the fornix and hippocampal atrophy in Alzheimer’s disease</article-title>. <source>Front Aging Neurosci</source>. <year>2014</year>;<volume>6</volume>:<fpage>316</fpage>.<pub-id pub-id-type="pmid">25431558</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnagi.2014.00316</pub-id><pub-id pub-id-type="pmcid">PMC4230048</pub-id></mixed-citation></ref><ref id="gps5540-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="gps5540-cit-0043"><string-name name-style="western"><surname>Leoutsakos</surname><given-names>J‐MS</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>WS</given-names></string-name>, et al. <article-title>Deep brain stimulation targeting the fornix for mild Alzheimer dementia (the ADvance trial): a two year follow‐up including results of delayed activation</article-title>. <source>J Alzheimer's Dis</source>. <year>2018</year>;<volume>64</volume>(<issue>2</issue>):<fpage>597</fpage>‐<lpage>606</lpage>.<pub-id pub-id-type="pmid">29914028</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-180121</pub-id><pub-id pub-id-type="pmcid">PMC6518401</pub-id></mixed-citation></ref><ref id="gps5540-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="gps5540-cit-0044"><string-name name-style="western"><surname>Wang</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Yao</surname><given-names>H</given-names></string-name>, et al. <article-title>Aberrant hippocampal functional connectivity is associated with fornix white matter integrity in Alzheimer’s disease and mild cognitive impairment</article-title>. <source>J Alzheimer's Dis</source>. <year>2020</year>;(Preprint):<volume>75</volume>(<issue>4</issue>):<fpage>1153</fpage>‐<lpage>1168</lpage>.<pub-id pub-id-type="pmid">32390630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-200066</pub-id></mixed-citation></ref><ref id="gps5540-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="gps5540-cit-0045"><string-name name-style="western"><surname>Ewers</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sperling</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Klunk</surname><given-names>WE</given-names></string-name>, <string-name name-style="western"><surname>Weiner</surname><given-names>MW</given-names></string-name>, <string-name name-style="western"><surname>Hampel</surname><given-names>H</given-names></string-name>. <article-title>Neuroimaging Markers for the Prediction and Early Diagnosis of Alzheimer's Disease Dementia</article-title>. <source>Trend in neurosciences</source>. <year>2011</year>;<volume>34</volume>(<issue>8</issue>):<fpage>430</fpage>‐<lpage>432</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tins.2011.05.005</pub-id><pub-id pub-id-type="pmcid">PMC3275347</pub-id><pub-id pub-id-type="pmid">21696834</pub-id></mixed-citation></ref><ref id="gps5540-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="gps5540-cit-0046"><string-name name-style="western"><surname>Mak</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Gabel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mirette</surname><given-names>H</given-names></string-name>, et al. <article-title>Structural neuroimaging in preclinical dementia: from microstructural deficits and grey matter atrophy to macroscale connectomic changes</article-title>. <source>Ageing Res Rev</source>. <year>2017</year>;<volume>35</volume>:<fpage>250</fpage>‐<lpage>264</lpage>.<pub-id pub-id-type="pmid">27777039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arr.2016.10.001</pub-id></mixed-citation></ref><ref id="gps5540-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="gps5540-cit-0047"><string-name name-style="western"><surname>Zhuang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Sachdev</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Trollor</surname><given-names>JN</given-names></string-name>, et al. <article-title>Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>:<elocation-id>e58887</elocation-id>.<pub-id pub-id-type="pmid">23516569</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0058887</pub-id><pub-id pub-id-type="pmcid">PMC3597581</pub-id></mixed-citation></ref><ref id="gps5540-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="gps5540-cit-0048"><string-name name-style="western"><surname>Rosenberg</surname><given-names>PB</given-names></string-name>, <string-name name-style="western"><surname>Nowrangi</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Lyketsos</surname><given-names>CG</given-names></string-name>. <article-title>Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits?</article-title><source>Mol Aspects Med</source>. <year>2015</year>;<volume>43‐44</volume>:<fpage>25</fpage>‐<lpage>37</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mam.2015.05.005</pub-id><pub-id pub-id-type="pmcid">PMC4600424</pub-id><pub-id pub-id-type="pmid">26049034</pub-id></mixed-citation></ref><ref id="gps5540-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="gps5540-cit-0049"><string-name name-style="western"><surname>Apostolova</surname><given-names>LG</given-names></string-name>, <string-name name-style="western"><surname>Di</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Duffy</surname><given-names>EL</given-names></string-name>, et al. <article-title>Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease</article-title>. <source>Dementia Geriatr Cogn Disord</source>. <year>2014</year>;<volume>37</volume>(<issue>5‐6</issue>):<fpage>315</fpage>‐<lpage>326</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000351009</pub-id><pub-id pub-id-type="pmcid">PMC4057985</pub-id><pub-id pub-id-type="pmid">24481207</pub-id></mixed-citation></ref><ref id="gps5540-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="gps5540-cit-0050"><string-name name-style="western"><surname>Ott</surname><given-names>BR</given-names></string-name>, <string-name name-style="western"><surname>Tate</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Gordon</surname><given-names>NM</given-names></string-name>, <string-name name-style="western"><surname>Heindel</surname><given-names>WC</given-names></string-name>. <article-title>Gender differences in the behavioral manifestations of Alzheimer's disease</article-title>. <source>J Am Geriatr Soc</source>. <year>1996</year>;<volume>44</volume>(<issue>5</issue>):<fpage>583</fpage>‐<lpage>587</lpage>.<pub-id pub-id-type="pmid">8617910</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1532-5415.1996.tb01447.x</pub-id></mixed-citation></ref><ref id="gps5540-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="gps5540-cit-0051"><string-name name-style="western"><surname>Zuidema</surname><given-names>SU</given-names></string-name>, <string-name name-style="western"><surname>de Jonghe</surname><given-names>JFM</given-names></string-name>, <string-name name-style="western"><surname>Verhey</surname><given-names>FRJ</given-names></string-name>, <string-name name-style="western"><surname>Koopmans</surname><given-names>RTCM</given-names></string-name>. <article-title>Predictors of neuropsychiatric symptoms in nursing home patients: influence of gender and dementia severity</article-title>. <source>Int J Geriatr Psychiatr</source>. <year>2009</year>;<volume>24</volume>(<issue>10</issue>):<fpage>1079</fpage>‐<lpage>1086</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/gps.2225</pub-id><pub-id pub-id-type="pmid">19280678</pub-id></mixed-citation></ref><ref id="gps5540-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="gps5540-cit-0052"><string-name name-style="western"><surname>Xing</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>J</given-names></string-name>. <article-title>Sex differences in neuropsychiatric symptoms of Alzheimer’s disease: the modifying effect of apolipoprotein E ε4 status</article-title>. <source>Behav Neurol</source>. <year>2015</year>;<volume>2015</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2015/275256</pub-id><pub-id pub-id-type="pmcid">PMC4619911</pub-id><pub-id pub-id-type="pmid">26538817</pub-id></mixed-citation></ref><ref id="gps5540-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="gps5540-cit-0053"><string-name name-style="western"><surname>Mortby</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Black</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Gauthier</surname><given-names>S</given-names></string-name>, et al. <article-title>Dementia clinical trial implications of mild behavioral impairment</article-title>. <source>Int Psychogeriatr</source>. <year>2018</year>;<volume>30</volume>(<issue>2</issue>):<fpage>171</fpage>‐<lpage>175</lpage>.<pub-id pub-id-type="pmid">29448970</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1041610218000042</pub-id></mixed-citation></ref><ref id="gps5540-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="gps5540-cit-0054"><string-name name-style="western"><surname>Ismail</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Agüera‐Ortiz</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Brodaty</surname><given-names>H</given-names></string-name>, et al. <article-title>The mild behavioral impairment checklist (MBI‐C): a rating Scale for neuropsychiatric symptoms in pre‐dementia populations</article-title>. <source>J Alzheimer's Dis</source>. <year>2017</year>;<volume>56</volume>(<issue>3</issue>):<fpage>929</fpage>‐<lpage>938</lpage>.<pub-id pub-id-type="pmid">28059789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-160979</pub-id><pub-id pub-id-type="pmcid">PMC5652315</pub-id></mixed-citation></ref><ref id="gps5540-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="gps5540-cit-0055"><string-name name-style="western"><surname>Kassam</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>HY</given-names></string-name>, <string-name name-style="western"><surname>Nosheny</surname><given-names>RL</given-names></string-name>, et al. <article-title>Cognitive profile of mild behavioral impairment (MBI) in brain health registry participants</article-title>. <source>Alzheimer's Dementia</source>. <year>2020</year>;<volume>16</volume>:<elocation-id>e047673</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1041610221002878</pub-id><pub-id pub-id-type="pmcid">PMC10063171</pub-id><pub-id pub-id-type="pmid">35130991</pub-id></mixed-citation></ref><ref id="gps5540-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="gps5540-cit-0056"><string-name name-style="western"><surname>Saari</surname><given-names>T.</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>EE.</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>Z.</given-names></string-name><article-title>Network analysis of impulse dyscontrol in mild cognitive impairment and subjective cognitive decline</article-title>. <source>International Psychogeriatrics</source>. <year>2021</year>;<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1017/s1041610220004123</pub-id><pub-id pub-id-type="pmid">33583464</pub-id></mixed-citation></ref></ref-list></back></article>